Short-term interruption versus continuous anticoagulation in colorectal polypectomy. A randomized multicenter investigator-initiated non-inferiority clinical trial: the POLYPHEM trial.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512194-27-01

Enrollment

394

Registered

2024-06-18

Start date

2024-10-21

Completion date

Unknown

Last updated

2025-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients receiving oral anticoagulant therapy who are scheduled for elective colonoscopy for any indication.

Brief summary

Occurrence of haemorrhage and thromboembolic events post-polypectomy

Interventions

DRUGDABIGATRAN ETEXILATE

DRUGACENOCOUMAROL

DRUGWARFARIN

DRUGAPIXABAN

DRUGEDOXABAN

DRUGRIVAROXABAN

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Occurrence of haemorrhage and thromboembolic events post-polypectomy	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026